Steatosis Clinical Trials

1 recruiting

Steatosis Trials at a Glance

21 actively recruiting trials for steatosis are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Athens, Lisbon, and Amsterdam. Lead sponsors running steatosis studies include Carol Davila University of Medicine and Pharmacy, Catholic University of the Sacred Heart, and AdventHealth Translational Research Institute.

Browse steatosis trials by phase

Treatments under study

About Steatosis Clinical Trials

Looking for clinical trials for Steatosis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Steatosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Steatosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Not Applicable

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Type 2 DiabetesHepatic Steatosis
AdventHealth Translational Research Institute12 enrolled1 locationNCT06993454
Recruiting
Not Applicable

Siemens Biomarker Multi-modality

Fatty LiverHepatic Steatosis
Duke University45 enrolled1 locationNCT07495332
Recruiting
Phase 1

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

Healthy VolunteersHepatic Steatosis
Novo Nordisk A/S48 enrolled1 locationNCT06891365
Recruiting
Not Applicable

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

Diabetes MellitusPancreatic SteatosisMetabolic Syndrome X
Catholic University of the Sacred Heart100 enrolled2 locationsNCT06801769
Recruiting

Incidence of Liver Disease-Related Outcomes in People With HIV

Liver FibrosisHIVHepatic Steatosis+3 more
Shanghai Public Health Clinical Center320 enrolled2 locationsNCT06940375
Recruiting
Not Applicable

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatic SteatosisLiver Disease Parenchymal
Seoul National University Hospital62 enrolled2 locationsNCT07192159
Recruiting
Not Applicable

Identification of a Score for the Assessment of Intrapancreatic Fat

DiabetesPancreatic SteatosisMetabolic Syndrome X
Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled1 locationNCT07155473
Recruiting
Phase 3

Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)

NAFLDHepatic SteatosisAdolescent Obesity
University of Colorado, Denver55 enrolled1 locationNCT05935826
Recruiting
Not Applicable

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

MASLDMASH - Metabolic Dysfunction-Associated SteatohepatitisNAFLD+4 more
E-Scopics120 enrolled3 locationsNCT06661655
Recruiting
Not Applicable

Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features

Pancreatic CystPancreatic Steatosis
Chinese University of Hong Kong236 enrolled1 locationNCT05334836
Recruiting
Not Applicable

Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

MASH - Metabolic Dysfunction-Associated SteatohepatitisSteatosis of LiverMASH With Fibrosis
Queen Mary University of London72 enrolled2 locationsNCT07013916
Recruiting
Not Applicable

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD

Chronic Kidney Disease(CKD)Muscle FunctionMyosteatosis+2 more
Karolinska Institutet10 enrolled1 locationNCT06631820
Recruiting

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

Pancreatic AdenocarcinomaPancreatic CystPancreatic Steatosis
Carol Davila University of Medicine and Pharmacy66 enrolled1 locationNCT06867172
Recruiting

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Liver FibrosisHepatic SteatosisMetabolic Dysfunction-associated Fatty Liver Disease
Chongqing Medical University7,000 enrolled1 locationNCT05974904
Recruiting

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Inflammatory Bowel DiseasesFibrosis, LiverNAFLD+1 more
Centre Hospitalier Universitaire Saint Pierre150 enrolled1 locationNCT06814600
Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Diabetes MellitusInsulin Sensitivity/ResistanceObesity+16 more
Osaka Metropolitan University2,000 enrolled1 locationNCT06694012
Recruiting
Phase 2

Soluble Fibre Supplementation in NAFLD

Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisHepatic Steatosis
McMaster University60 enrolled1 locationNCT05480696
Recruiting

Global Research Initiative for Patients Screening on MASH

ObesityMetabolic SyndromeMASLD+6 more
Julius Clinical10,000 enrolled13 locationsNCT05651724
Recruiting
Phase 1

Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)

ObesityMetabolic SyndromeSteatosis of Liver
Max Nieuwdorp20 enrolled1 locationNCT06502834
Recruiting

The European NAFLD Registry

Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334